147 related articles for article (PubMed ID: 10129049)
1. User fees to fund faster reviews.
Henkel J
FDA Consum; 1993 Oct; 27(8):19-21. PubMed ID: 10129049
[No Abstract] [Full Text] [Related]
2. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
Zelenay JL
Food Drug Law J; 2005; 60(2):261-338. PubMed ID: 16094773
[No Abstract] [Full Text] [Related]
3. User fees for faster drug reviews. Are they helping or hurting the public health?
Thompson L
FDA Consum; 2000; 34(5):25-9. PubMed ID: 11590789
[No Abstract] [Full Text] [Related]
4. The Prescription Drug User Fee Act of 1992: speeding up the drug approval process.
Bierut MB
Healthspan; 1992 Dec; 9(11):12-4. PubMed ID: 10123552
[No Abstract] [Full Text] [Related]
5. Paying for drug approvals--who's using whom?
Avorn J
N Engl J Med; 2007 Apr; 356(17):1697-700. PubMed ID: 17435083
[No Abstract] [Full Text] [Related]
6. PDUFA reauthorization--drug safety's golden moment of opportunity?
Hennessy S; Strom BL
N Engl J Med; 2007 Apr; 356(17):1703-4. PubMed ID: 17435082
[No Abstract] [Full Text] [Related]
7. FDA joins market.
Gershon D
Nature; 1993 Jul; 364(6433):93. PubMed ID: 8321293
[No Abstract] [Full Text] [Related]
8. Drug safety reform at the FDA--pendulum swing or systematic improvement?
McClellan M
N Engl J Med; 2007 Apr; 356(17):1700-2. PubMed ID: 17435081
[No Abstract] [Full Text] [Related]
9. User fees and beyond--the FDA Safety and Innovation Act of 2012.
Kramer DB; Kesselheim AS
N Engl J Med; 2012 Oct; 367(14):1277-9. PubMed ID: 23034017
[No Abstract] [Full Text] [Related]
10. Whatever happened to user fees and the FDA's promise to expedite new drug approvals?
Gatty B
Hosp Formul; 1993 Jul; 28(7):656, 655. PubMed ID: 10127048
[No Abstract] [Full Text] [Related]
11. The FDA's drug review process: ensuring drugs are safe and effective.
Meadows M
FDA Consum; 2002; 36(4):19-24. PubMed ID: 12184298
[No Abstract] [Full Text] [Related]
12. New drug law to speed scientific review.
Nature; 1992 Oct; 359(6396):563. PubMed ID: 1406977
[TBL] [Abstract][Full Text] [Related]
13. User fees to hasten FDA review.
Gershon D
Nature; 1992 Oct; 359(6396):567. PubMed ID: 1406982
[No Abstract] [Full Text] [Related]
14. Food and Drug Administration.
Horton LR
BMJ; 2007 Jan; 334(7584):55-6. PubMed ID: 17218671
[TBL] [Abstract][Full Text] [Related]
15. Medical device technology user fees.
Bailey PG
Med Device Technol; 2002 Sep; 13(7):37-8. PubMed ID: 12397834
[TBL] [Abstract][Full Text] [Related]
16. FDA dependence on drug industry.
Lawson GW
J Natl Med Assoc; 2005 Jul; 97(7):1039-40. PubMed ID: 16080677
[No Abstract] [Full Text] [Related]
17. FDA proposes higher fees for drug approvals to cover postmarketing surveillance.
Tanne JH
BMJ; 2007 Jan; 334(7586):177. PubMed ID: 17255596
[No Abstract] [Full Text] [Related]
18. FDA user fees approved.
Clin Pharm; 1993 Jan; 12(1):3. PubMed ID: 8428431
[No Abstract] [Full Text] [Related]
19. FDA user fees and innovation.
Somberg J
Am J Ther; 2008; 15(2):97. PubMed ID: 18356626
[No Abstract] [Full Text] [Related]
20. The risk we bear: the effects of review speed and industry user fees on new drug safety.
Olson MK
J Health Econ; 2008 Mar; 27(2):175-200. PubMed ID: 18207263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
